round button
Leave a message

全球下一代癌症诊断市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球下一代癌症诊断市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Next Generation Cancer Diagnostics Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 8.39 Billion
Diagram Market Size (Forecast Year)
USD 31.75 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球下一代癌症诊断市场,按技术(NGS、LOAC 和 RT-PCR)、应用(CTC、生物标志物)、癌症类型(肺癌、乳腺癌)划分 - 行业趋势和预测至 2029 年

下一代癌症诊断市场

市场分析和规模

预计全球下一代癌症诊断市场将在预测期内出现显着增长。下一代癌症诊断有助于癌症的早期发现和预防。研究人员不断致力于开发新的癌症诊断工具并改进现有的工具。许多市场公司正在合作开发新的癌症生物标志物和检测方法,从而推动市场增长。癌症诊断有助于早期发现癌症,从而提供更好的治疗选择。下一代癌症诊断有助于以完全准确和低成本的方式检测疾病。

Data Bridge Market Research 分析了 2022-2029 年预测期内全球下一代癌症诊断市场的增长率。在上述预测期内,全球下一代癌症诊断市场的预期复合年增长率约为 18.1%。2021 年市场价值为 83.9 亿美元,到 2029 年将增长至 317.5 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

市场定义

癌症诊断是一种检测大量生物标志物、蛋白质和某些症状的过程,可检测出患者体内是否存在癌性肿瘤。检测癌症的过程包括广泛使用某些专门用于诊断的技术和设备。这些测试旨在促进早期诊断,并对不同类型的癌症提供有效的预测,从而有望在预测期内对该市场的发展产生积极影响。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按技术(NGS、LOAC 和 RT-PCR)、应用(CTC、生物标志物)、癌症类型(肺癌、乳腺癌)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Agilent Technologies, Inc. (U.S.), Abbott (U.S.), BD (U.S.), bioMérieux SA (France), NeoGenomics Laboratories, Inc. (U.S.), Telerad Tech (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GENERAL ELECTRIC COMPANY (U.S.), Hologic Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), BioGenex (China), Siemens Healthcare GmbH (Germany), BioNTech SE (Germany), Thermo Fisher Scientific Inc. (India), Koninklijke Philips N.V. (Netherlands), PerkinElmer Inc (U.S.), OPKO Health, Inc. (U.S.), Cepheid (U.S.)

Market Opportunities

  • Increase in Geriatric Population
  • Prevalence of Software

Global Next Generation Cancer Diagnostics Market Dynamics

Drivers

  • Increasing Cancer Cases

Cancer is the leading cause of death in many countries, followed by other diseases such as stroke and coronary artery disease. Next-generation cancer diagnostic tests help prevent and detect illness early and, as a result, improve mortality worldwide.

  • Advanced Technology

Advances in diagnostic labs and the introduction of integrated and automated lab systems are also expected to drive demand for advanced workflow systems and increase revenue during the forecast period. In addition, the transition from traditional clinical testing to rapid point-of-care testing will support market expansion as it is expected to commercialize a technologically advanced range of products such as diagnostic kits, instruments and reagents.

Opportunities

  • Increase in Geriatric Population

The rise in elderly population face varied diseased conditions and increased cancer cases. There are several cancer types that are more prone to elderly population. Hence, these next-generation cancer diagnostics tools is surely going to aid in the further treatment process.

  • Prevalence of Software

The advantages, comprising detection of gene duplications or deletions,qPCR technology for tumor profiling in clinical laboratories and melting curve analysis for identification of mutations are the advanced software tools that are prompting the market growth.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to use these diagnostics tests could curb the growth of the global enhanced ambulatory patient grouping software market over a forecast period.

  • High Cost

High cost of these screening tests can hinder the growth of the global next generation cancer diagnostics market even though the prevalence of the patients are high.

This global next generation cancer diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global next generation cancer diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Next Generation Cancer Diagnostics Market

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period.

With the reopening of the hospitals and research institutes for all the diseased conditions other than COVID-19 patients, the market is slowly seeing a huge growth and is expected to witness a huge rise up in the forecast period.  

Global Next Generation Cancer Diagnostics Market Scope

The global next generation cancer diagnostics market is segmented on the basis of technology, application and cancer type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • NGS
  • LOAC
  • RT-PCR

Application

  • CTC
  • Biomarker

Cancer Type

  • Lung
  • Breast

Next Generation Cancer Diagnostics Market Regional Analysis/Insights

The global next generation cancer diagnostics market is analysed and market size insights and trends are provided by Technology, Application, Cancer type as referenced above.

The major countries covered in the global next generation cancer diagnostics market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the next generation cancer diagnostics market due to increased prevalence of cancer in this region. Asia-Pacific is the expected region in terms of growth in next generation cancer diagnostics market.

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球下一代癌症诊断市场份额分析

全球下一代癌症诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球下一代癌症诊断市场的关注有关。

全球下一代癌症诊断市场的主要参与者包括:

  • 安捷伦科技公司(美国)
  • 雅培(美国)
  • BD(美国)
  • 生物梅里埃公司(法国)
  • NeoGenomics Laboratories, Inc.(美国)
  • Telerad Tech(美国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • 通用电气公司(美国)
  • Hologic Inc.(美国)
  • Illumina 公司(美国)
  • QIAGEN(德国)
  • BioGenex (中国)
  • 西门子医疗有限公司(德国)
  • BioNTech SE(德国)
  • 赛默飞世尔科技公司 (印度)
  • Koninklijke Philips NV(荷兰)
  • PerkinElmer Inc(美国)
  • OPKO Health, Inc.(美国)
  • 造父变星(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The global next generation cancer diagnostics market is expected USD 31.75 billion by 2029.
The Next Generation Cancer Diagnostics Market is to grow at a CAGR of 18.1% during the forecast by 2029.
On the basis of technology, the Next Generation Cancer Diagnostics Market is segmented into NGS, LOAC and RT-PCR.
On the basis of application, the Next Generation Cancer Diagnostics Market is segmented into CTC, & Biomarker.
a